A critical discovery in cancer investigation is emerging with the use of mini-antibodies to restore dysfunctional p53. This vital malignant protector protein is frequently inactivated in various forms of cancer, https://socials360.com/story12632218/vhh-fragments-restore-the-p53-protein-the-new-pathway-for-malignant-management